5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Asia Pacific Beta-Glucan Market is segmented By Category (Soluble and Insoluble) By Application (Food and Beverage, Healthcare and Dietary Supplements and Other Applications), By Source (Cereals, Yeast, Mushroom, and Other Sources), and By Geography.
Asia Pacific Beta-Glucan market is projected to grow at a CAGR of 5.75% during the forecast period (2020 - 2025).
The Asia-Pacific Beta-Glucan market is segmented by category that includes soluble and insoluble. Based on the application, the market is divided into food and beverage, healthcare and dietary supplements, and other applications. The market is also classified according to the source including cereals, yeast, mushroom, and other sources. The study also involves the analysis of regions such as China, Japan, India, Australia, and the rest of Asia-Pacific.
|Food and Beverages|
|Healthcare and Dietary Supplements|
|Rest of Asia-Pacific|
Report scope can be customized per your requirements. Click here.
In the healthcare industry, beta-glucans are used for improving immune response and are used as oral medicines or injections for treating a range of medical diseases and disorders including high cholesterol, Crohn’s disease, diabetes, cancer, and high blood pressure. Thus, the increasing applications of beta-glucan in the healthcare industry have led to manufacturers offering beta-glucan to carry out research studies and introduce potent drugs. Consumers following a healthy and active lifestyle are opting for dietary supplements to increase vitality, physical endurance, and boost their metabolism rate. This demand has led to food companies use beta-glucan to create solutions that improve the overall health of consumers.
To understand key trends, Download Sample Report
The infant formula market in China has been witnessing significant growth from the past couple of years, owing to the increasing demand and growing unit prices. After the two-child policy was officially executed in October 2015, the new-born population increased, which has been strengthening the need for infant formula from 2017. Increasing government support for product innovation in infant formula has encouraged the key players to introduce an infant formula with beta-glucan ingredients. For instance, in 2016, the China National Center for Food Safety Risk Assessment (CFSA) permitted the application of beta-glucan in infant formula and asked to expand the scope of this material as a nutrition enhancer. The change in the regulation related to the beta-glucan application has created a positive impact on the market growth in the country, especially yeast glucan application in the food and beverage sector
To understand geography trends, Download Sample Report.
The Asia Pacific beta-glucan market is highly fragmented, particularly with the significant presence of numerous global and regional players. The market is dominated by the players, such as Tate & Lyle, Kerry Group, Associated British Foods Plc, and Koninklijke DSM N.V., among others. The prominent companies in the market are focusing on the innovation and distribution of these ingredients for catering to emerging applications, like infant nutrition. In addition, the leading players are focused on the promotion of their beta-glucan ingredients, along with spreading awareness among the consumers.
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Category
5.2 By Application
5.2.1 Food and Beverages
5.2.2 Healthcare and Dietary Supplements
5.2.3 Other Applications
5.3 By Source
5.3.4 Other Sources
5.4 By Geography
5.4.5 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
6.1 Most Adopted Strategies
6.2 Market Position Analysis
6.3 Company Profiles
6.3.1 Tate & Lyle PLC
6.3.2 Kerry Group plc
6.3.3 Koninklijke DSM N.V.
6.3.4 Associated British Foods Plc
6.3.5 Kemin Industries, Inc.
6.3.6 Angel Yeast Co. Ltd
6.3.7 Merck KGaA
7. MARKET OPPORTUNITIES AND FUTURE TRENDS